Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Ottawa
$27,000.00
Bacteriophage Therapy to Treat Fracture-Related Infections and Restore Bone Healing
FY 2025-26
Summary
Fracture-related infections (FRIs) are one of the most challenging complications in orthopedic trauma, often leading to repeat surgeries, prolonged antibiotic use, delayed healing, and long-term disability. Staphylococcus aureus is the most common cause and is difficult to eliminate because it forms biofilms, invades bone cells, and persists deep within bone structures. These mechanisms allow the bacteria to evade immune clearance and antibiotic treatment, creating chronic inflammation that disrupts normal bone repair. Although bacteriophage (phage) therapy has emerged as a promising option for treating antibiotic-resistant infections, its effects on fracture healing remain poorly understood.
The goal of this project is to determine whether phage therapy can treat S. aureus FRIs and restore normal bone repair. I will use a stabilized mouse femur fracture model to characterize baseline healing, develop a bioluminescent S. aureus infection model, and evaluate whether local delivery of phage K reduces bacterial burden and improves healing outcomes. Imaging (x-ray, IVIS, confocal microscopy) and histology will be used to assess infection control, inflammatory responses, vascularization, and callus formation.
This research addresses a major knowledge gap by directly testing how phage therapy influences both infection and bone healing in vivo. The results will provide foundational evidence for phage therapy as a potential adjunct to surgery and antibiotics, with the long-term goal of improving clinical outcomes for patients with fracture-related infections.
Department
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
582693
Name
Le Benjamin Tung
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Bacteriophage Therapy to Treat Fracture-Related Infections and Restore Bone Healing
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Antibiotic Resistance; Bacteriophage Therapy; Bone Healing Impairment; Fracture-Related Infections; Implant-Associated Infection; Infection Model Development; Intramedullary Implant Infection; Murine Femur Fracture Model; Orthopedic Trauma; Staphylococcus Aureus
Abstract
Fracture-related infections (FRIs) are one of the most challenging complications in orthopedic trauma, often leading to repeat surgeries, prolonged antibiotic use, delayed healing, and long-term disability. Staphylococcus aureus is the most common cause and is difficult to eliminate because it forms biofilms, invades bone cells, and persists deep within bone structures. These mechanisms allow the bacteria to evade immune clearance and antibiotic treatment, creating chronic inflammation that disrupts normal bone repair. Although bacteriophage (phage) therapy has emerged as a promising option for treating antibiotic-resistant infections, its effects on fracture healing remain poorly understood.
The goal of this project is to determine whether phage therapy can treat S. aureus FRIs and restore normal bone repair. I will use a stabilized mouse femur fracture model to characterize baseline healing, develop a bioluminescent S. aureus infection model, and evaluate whether local delivery of phage K reduces bacterial burden and improves healing outcomes. Imaging (x-ray, IVIS, confocal microscopy) and histology will be used to assess infection control, inflammatory responses, vascularization, and callus formation.
This research addresses a major knowledge gap by directly testing how phage therapy influences both infection and bone healing in vivo. The results will provide foundational evidence for phage therapy as a potential adjunct to surgery and antibiotics, with the long-term goal of improving clinical outcomes for patients with fracture-related infections.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Le, Benjamin Tung
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~